Brief: Cosmo Pharmaceuticals' Rifamycin SV MMX Gets Marketing Authorization In Italy

Cosmo NV

08/07/2020 06:06

July 8 (Reuters) - COSMO PHARMACEUTICALS NV  COPN.S :
    * ANNOUNCES GRANTING OF MARKETING AUTHORIZATION IN ITALY TO
RIFAMYCIN SV MMX (STADMYCIN™) BY ITALIAN AIFA
    * WILL RECEIVE A MILESTONE PAYMENT OF EUR 1.5M FROM E.G. DUE
ON
GRANT OF THIS MARKETING AUTHORIZATION

Source text for Eikon:  ID: 
Further company coverage:  COPN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))